- Home
- USNA vs VOR Comparison
USNA vs VOR Comparison
Compare USNA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USNA | VOR |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.3M | 345.1M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | USNA | VOR |
|---|---|---|
| Price | $21.43 | $13.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $36.00 | ★ $64.78 |
| AVG Volume (30 Days) | 112.4K | ★ 952.8K |
| Earning Date | 02-17-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $912,670,000.00 | N/A |
| Revenue This Year | $10.42 | N/A |
| Revenue Next Year | $3.37 | N/A |
| P/E Ratio | $23.59 | ★ N/A |
| Revenue Growth | ★ 5.88 | N/A |
| 52 Week Low | $18.48 | $2.62 |
| 52 Week High | $38.32 | $65.80 |
Technical Indicators
Market Signals| Indicator | USNA | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 54.48 | 51.66 |
| Support Level | $20.57 | $11.46 |
| Resistance Level | $21.98 | $13.80 |
| Average True Range (ATR) | 0.79 | 1.23 |
| MACD | -0.10 | -0.19 |
| Stochastic Oscillator | 47.74 | 38.18 |
Price Performance
Historical ComparisonAbout USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.